neurosurgical focus
spinous process devices (IPDs) have been introduced to the market and are currently available. 16, 26, 24, 28, 29, 31, 39 They can be categorized as static or dynamic, and material compositions include titanium, polyetheretherketone (PEEK), and elastomeric compounds. 1, 13, 15, 17, 25, 27, 31, 35, 36, 45 Surgical indications have been extended, ranging from degenerative spinal stenosis, discogenic low-back pain, facet syndrome, disc herniations, and low-grade instability. These devices are used either as "stand-alone" implants or to augment open decompression by preventing instability. One concern regarding this surgical technique is the relative structural weakness of the spinous processes: placement of an interspinous process spacer changes the mechanical role of the spinous process from a primary tension-bearing structure to a compression-loading one. However, the Food and Drug Administration investigational device exemption study for the X-Stop system (Medtronic) reported spinous process fractures as a relatively rare complication at the 2-year follow-up. 51 But despite initial enthusiasm for the IPD as a safe, effective, and minimally invasive surgical alternative for the relief of neurological symptoms in patients with low-back degenerative disease, recent studies have demonstrated less impressive clinical results as well as a higher rate of failure than initial reports. We present our experience in a selected cohort of patients who underwent IPD insertion for various lumbar spine diseases. The aim of this study was to investigate the possible complications and failure rate associated with interspinous spacer placement.
methods
The medical records of all patients who had undergone placement of an IPD for the treatment of degenerative lumbar spinal disease were retrospectively evaluated. All of these patients had symptoms of low-back pain, radiculopathy, and neurogenic claudication and were evaluated using MRI or CT studies of the lumbar spine. Only patients whose symptoms improved by bending forward were treated with IPD implantation alone or in combination with other surgical interventions (that is, microdiscectomy, foraminotomy, hemilaminectomy). Patients treated with IPD insertion in combination with interbody fusion (extreme lateral lumbar interbody fusion, posterior lumbar interbody fusion, and transforaminal lumbar interbody fusion) were excluded.
Demographic information, diagnosis, comorbidities, and preoperative pain levels were recorded. Preoperative and postoperative clinical assessments of the patients were based on the visual analog scale (VAS). A minimum of 3 years after IPD placement, information on long-term outcomes was obtained from additional follow-up or from patient medical and radiological records. Anteroposterior and/or lateral lumbar spine radiographs were evaluated to check the device position.
Patient satisfaction and postoperative pain outcomes were assessed using the rating scale of Finneson and Cooper, 9 a lumbar disc surgery questionnaire that categorizes the postoperative assessment of patients into a 5-grade classification, from excellent to poor. Early postoperative and long-term follow-up complications were evaluated.
Revision surgeries such as IPD removal, laminectomy, and spinal fusion were recorded.
results
Between January 2002 and January 2012, 1108 consecutive patients (593 men and 515 women) underwent placement of an IPD. Their mean age was 59 years (range 21-82 years; Table 1 ). Relevant medical history included hypertension (76 patients), chronic vascular disease (53 patients), diabetes (48 patients), asthma (24 patients), chronic lung disease (29 patients), and thyroid disease (25 patients). The most common pathology treated was lumbar stenosis (444), followed by herniated disc (223), minor instability associated or not with herniated disc (174 and 129, respectively), and listhesis (31; Table 2 ).
The most common IPDs implanted were X-Stop, accounting for 422 cases, whereas DIAM insertion was performed in 193 cases and Viking implant in 185 patients. The operations were performed with the patient under general anesthesia in 950 cases and under local anesthesia in 158 cases.
In most cases (592 of 1108 patients), the L4-5 level was affected. The operation was performed at L3-4 in 138 patients and at L5-S1 in 229 patients; in 34 cases a device was implanted at the L2-3 level (Table 3 ). The interspinous spacer was implanted at 2 levels in 115 cases (Table 4) .
The median operative time was 37 minutes (range 15-55 minutes) for the single level and 73 minutes (range 35-135 minutes) for the multiple levels, with an average blood loss of 48 ml per procedure. No drainage was necessary at the implant site.
clinical results
The mean postoperative follow-up was 44.8 months (range 36-128 months). Estimation of survival over time was performed with a Kaplan-Meier analysis (Fig. 1) .
Directly postoperatively, 13 patients experienced the persistence, early recurrence, or worsening of symptoms and thus underwent revision surgery in the 1st month after surgery. All patients with persistent or recurrent symptoms underwent postoperative MRI. Aside from 14 cases of acute low-back pain secondary to IPD malposition (with an oversized or undersized implant), other complications developed acutely as a result of surgery during the first 3 postoperative months: 23 patients experienced dura mater tears and CSF leakage after insertion of the dilator instrument in the interspinous space (18 cases at L5-S1 and 5 cases at L4-5 level). The CSF fistula was immediately treated with a muscular graft inserted in the hole and fibrin glue in all cases. In 12 cases subcutaneous CSF collection without clinical symptoms was noted after surgery and resolved with subcutaneous tapping in 7 cases and spontaneously in 5 patients. There were 27 intraoperative fractures of the spinous process: in these patients, the fractures were probably attributable to osteopenic bone and were caused by excessive force of the distractor instrument used to distract the ligaments and determine the adequate size of the implant. There were 16 cases of wound infection, which resolved with antibiotic therapy; in no case was deep infection noted. In only 13 cases did we radiologically note deep vein thrombosis of the lower limbs.
implant survival Analysis
Eight hundred forty-four patients (76.2%) were very satisfied, 139 (12.5%) were somewhat satisfied, and 125 (11.3%) were not satisfied with the results of surgery after a minimum of 2 years of follow-up (Table 5 ).
In total, 107 patients had to undergo revision surgery during the long-term follow-up period. The presence of degenerative spondylolisthesis significantly increased the risk for reintervention (13 of 31 cases). The reasons for revision, which always consisted of removing the original implant, were acute worsening of low-back pain secondary to spinous fracture or overdistraction of the supraspinous ligament (27 cases), recurrence of symptoms after an initial good outcome (42 cases), total lack of improvement (18 cases), and implant dislocation (20 cases; Table 6 ).
In this study the overall reoperation rate was 9.6%: 24 revision surgeries consisted of removing the interspinous spacer and decompressive surgery, 63 cases required additional instrumented fusion with pedicle screws (Table 7) , 8 cases involved removal of the interspinous implant, and 12 cases required insertion of a new and bigger interspinous spacer.
When looking at the distribution of implant removal over time, we noted 2 stages: an early failure-stage (13 cases) within the first 3 months after surgery and another stage after a minimum of 2 years of follow-up (94 cases).
discussion
Interspinous process devices have been introduced as a possible alternative to spinal decompression and arthrodesis for the treatment of neurogenic claudication and discogenic low-back pain. Over the past several years, IPDs have gained popularity for the treatment of degenerative lumbar diseases. 1, 2, 17, 18, 20, 22, 42 Recent clinical and radiological evidence has shown beneficial effects such as increased spinal canal and neural foramen dimensions with lowered intradiscal pressure at the level of the device and decreased pressure at the facets. 2, 37 The surgical approach can be performed after inducing local spinal anesthesia with short procedures and hospitalizations. Hence, this procedure has been proposed to an older, high-risk population for the treatment of a broad spectrum of lumbar spine degenerative diseases. In fact, the encouraging initial results of this minimally invasive technique for spinal stenosis have led to an expansion of its surgical indications for various painful lumbar conditions such as herniated disc disease, degenerative spondylolisthesis, and low-back pain and in young patients as well. 12 Interspinous implants should theoretically prevent the development of the failed-back surgery syndrome by protecting the posterior spinal facet joints from overloading and restabilizing the intersegmental motion segment.
In the past years, we have seen a fairly increased number of young patients with degenerative disc disease, some with a severe type mainly related to their occupation. In young patients with huge disc herniations associated with microinstability, after microdiscectomy we implanted an IPD to prevent postoperative back pain and reduce the increased segmental flexion-extension and lateral bending motions observed after discectomy.
Previously reported complications associated with the use of interspinous spacers have included device dislocation or malposition, spinous process fractures, infection, hematoma, erosion of the spinous process, and neurological sequelae. 3, 7 We performed a retrospective, multicenter nonrandomized study consisting of 1108 patients to evaluate implant survival and failure modes after the implantation of IPDs. In our study, we found a less favorable outcome than in other investigational studies. 51, 52 Revision rates after XStop implantation were 6% in Zucherman et al.'s investigation. 52 Although our indications were based on generally accepted criteria, we noted a high rate of reintervention (9.6%), which is higher than the rates in the early literature. Part of the reason may be that our follow-up was substantially longer than that in other studies, which probably missed some late revisions. Another reason may be related to the implantation of oversized implants with overtension of the supraspinous ligament and higher compres- sion of the spinous process, whereas the under-tension of the ligamentum flavum with no improvement of pain and neurological signs may be secondary to undersized device implantation. Regardless, patient selection and surgical indication should be carefully considered.
In cases of late revision surgery, symptoms may recur late because of progressive narrowing of the spinal canal or subsidence of the implant with the loss of distraction. 36 Early or late failures due to fractures of the spinal process were mechanical failures.
Reoperation rates for IPD range from 4.6% to as high as 85% in studies with long-term follow-up. 4, 7, 10, 19, 32, 45, 47, 49, 51 In our study, the overall reoperation rate was 9.6%: We performed removal of the interspinous spacer and decompressive surgery in 24 patients, additional instrumented fusion with pedicle screws in 63 cases, removal of the interspinous spacer only in 8 cases, and insertion of a new interspinous implant in 12 cases. We removed the IPD with no further spinal fixation or decompression in older patients with multiple comorbidities in whom major spinal surgery could have been life threatening.
Data in the current study suggest that IPDs with a long follow-up may be associated with a higher rate of complications than previously reported.
Although the implantation of interspinous spacers is considered a less invasive procedure than the classic lumbar laminectomy for the treatment of lumbar spinal stenosis due to degenerative changes, our results showed that it is not an entirely benign operation, unless a careful analysis of the patient's indications is performed.
One of those interspinous spacers is the X-Stop device, which has shown efficacy as compared with conservative treatment. 3, 52 Although most published data show a stable clinical success rate over time, 51, 52 there are some reports of a less favorable outcome after an initial short-term improvement. 38 Bowers et al. showed a long-term complication rate of 38%, with 11 (85%) of 13 patients requiring additional spine surgery after X-Stop placement. 5 These authors observed a higher rate of spinous process fracture (23%) than previously reported.
In a retrospective study done by Tuschel et al., a fairly high revision rate (30.4%) was observed. 45 Fourteen cases had to undergo revision surgery due to worsening pain within the first 12 months in 11 cases, implant dislocation in 2 patients, and fracture of the spinous process in 1 case. In 1 case, spacer dislocation was secondary to trauma from a skiing accident. Verhoof et al. reported an extremely high failure rate for X-Stop interspinous distraction, defined by a requirement for surgical reintervention, in patients with lumbar spinal stenosis caused by degenerative spondylolisthesis with an average percentage of slip less than 25%. 47 Secondary surgery was required in 7 (58%) of 12 patients within 24 months. In another study, 42 patients with spinal stenosis secondary to lumbar degenerative spondylolisthesis and treated with X-Stop were compared with 33 patients who received nonoperative treatment. 3 Although the overall clinical success rate of 63.4% was achieved in the X-Stop group compared with 12.9% in the control group at 2 years of follow-up, surgical reintervention was required in 5 (11.9%) patients in the X-Stop group compared with 12.1% in the control group. In another study, since 80% of patients with Grade I spondylolisthesis required additional surgery after IPD placement, the authors supported the recommendation not to use X-Stop in patients with spondylolisthesis. 5 Stucki et al. reported 2-year outcomes in 197 patients with neurogenic intermittent claudication treated with lumbar laminectomy versus X-Stop-treated patients, demonstrating higher Zurich Claudication Questionnaire success rates than the scores for laminectomy patients. 40 Turner and colleagues evaluated the cost-effectiveness of X-Stop and laminectomy surgery during the index hospitalization for the treatment of 33 patients with lumbar spinal stenosis in the US. 44 Patients were matched for age, number of levels treated, and preoperative disability. XStop was shown to be significantly more cost-effective than laminectomy for the treatment of 1-and 2-level lumbar spinal stenosis. Furthermore, because there were no surgical complications in the IPD group with a shorter operative time as compared with the open decompression group, the authors suggested that this surgery may be preferred in older, destabilized patients with comorbidities.
Decompressive surgery with or without fusion is the 44 The overall complication rate in X-Stop surgery was 3.3%, including fracture of the spinous processes, dislocation of the prosthesis, and skin infections, whereas the rate for decompressive laminectomies was 9.7%. 44 Moreover, the decision to reoperate because of a lack of clinical improvement or the worsening of neurological symptoms is more easily taken after a less invasive procedure like interspinous device implantation than after open decompression of the spinal canal.
In our study, 20 patients experienced IPD dislocation with supraspinous ligament rupture. Interspinous process device dislocation may be attributed to the V-shaped appearance of the posterior interspinous spaces or may be secondary to accidental falls. In the study by Barbagallo et al., 4 patients experienced postoperative device dislocations, and in all cases revision surgery was required.
Instrumented fusion was performed in 1 case, whereas removal of the dislocated device alone was performed in the other patients because they did not consent to any further surgery. In all 4 cases, the supraspinous ligament was ruptured. 4 Few studies have reported the malposition of an IPD even when intraoperative radiographic guidance was used. Zhang et al. noted malpositioning of the Coflex device in 1 case, while Anderson et al. found 1 case of X-Stop malposition after postoperatively reviewing radiographic images in 191 cases. 3, 50 Although the IPD should be implanted deeply in the interspinous space, close to the zygapophysial joints, this correct position may be difficult to achieve in older patients with hypertrophy of the joints and pronounced osteophytes. In many of our cases, dislocation of the device occurred at the L5-S1 level, which is more difficult anatomically given a smaller S-1 spinous process.
Malpositioning of an IPD may be more frequent if the device is implanted percutaneously. In a prospective multicenter study on the safety and effectiveness of the Aperius IPD, 14 (9%) patients had their device removed during the 12-month postprocedural period because of persistent or recurring symptoms (10 cases), spinous process fracture (3 cases), or malpositioning (1 case). 46 In our study, 67 devices were implanted percutaneously. Of these, 3 were removed because of malpositioning, 1 because of spinous fracture, and 5 because of neurological worsening. In 4 cases with worsening or recurrent pain, conservative treatment was performed.
Normally, the spinous process is under tension from the interspinous ligament. But after placement of an IPD, this tension is altered, with higher compression of the spinous process. This pressure can lead to fracture of the spinous process. The incidence and clinical significance of spinous process fracture after IPD placement have yet to be clarified. One concern is the frequency of spinous process fractures documented on CT but missed on radiography. Postoperative spinous process fractures have been reported in 1%-5.8% of patients after plain radiographic spinal evaluation, but most fractures occur in the area between the base and the midportion of the spinous process, which is difficult to identify on radiography because of the spacer design and the osteopenic bone and metal in IPD spacers that can obscure the fracture. In a series of 38 patients treated with titanium or PEEK X-Stop and Lanx devices, the frequency of spinous fractures was 22% (11 patients), but only 5 patients with fracture were symp- tomatic, and just 3 required device removal and posterior decompression. 18 No fracture was visualized on plain radiographs, although in most cases it could be identified using thin-cut CT sagittal reformatted images. Barbagallo et al. described 69 cases in which an X-Stop device was implanted, and the main complications were spinous process fracture and implant displacement, with an incidence rate of 11.6%. In that study, 4 patients had spinous process fracture (1 intraoperatively, 3 postoperatively); the authors suggested that repetitive motion between 2 X-Stop devices may have caused excessive force resulting in a spinous process fatigue fracture. 4 In the study described by Zang et al., the complications included 5 spinous process fractures, associated with Coflex dislodgment in 1 case, for a complication incidence rate of 9.8%. 50 In our study, the reasons for the spinous process fractures were unknown, although possible factors include the patient's degree of osteoporosis and possible overdistraction of the interspinous space with a large interspinous device. Among our patients, 27 had a spinous process fracture (18 in the early postoperative period and 9 after 1 year postsurgery), which was symptomatic in 22. The IPD was removed in 22 cases. One patient experienced painful spontaneous spinal process fracture without any history of trauma or strenuous activity, after 4 years of follow-up, suggesting a possible fatigue fracture. Although reporting a VAS score of 8, the patient refused any further surgery. We suggest carefully evaluating the bone density of each patient preoperatively and considering whether a modest distraction and adequately sized device are needed to avoid spinous process fractures, especially in osteopenic/ osteoporotic patients (Figs. 2-4) .
Tian et al. investigated the incidence rate of heterotopic ossification after implantation of Coflex interspinous devices. Among a total of 32 cases, heterotopic ossification was detected in 81.2% (26 cases). In 8 patients, ossification occurred in the lateral space of the spinous process. In 16 patients, ossification occurred in the interspinous space but did not bridge the adjacent spinous processes, whereas interspinous fusion occurred in 2 patients. 43 None of the patients experienced a recurrence of symptoms resulting from the ossification. The significance of heterotopic ossification after IPD insertion is still unclear; large osteophytes could intrude into the spinal canal, compressing the dural sac. However, this outcome is very rare, with only 1 case reported. In the case described by Maida et al., neural structures were compressed by heterotopic bone, resulting in the recurrence of spinal stenosis symptoms. 23 Theoretically, interspinous ossification is not necessarily bad because it could enhance stabilization at the treated level.
Furthermore, in the last few years, new interspinous fusion devices have been used as an alternative to pedicle screws in achieving fusion (interspinous ossification) to treat degenerative lumbar instability or instability caused by decompressive lumbar surgery. 13 We observed that patients with X-Stop and Aperius devices were older than patients treated with other devices. In these cases, we suggest that poor bone quality may have resulted in a higher incidence of spinous fracture than in younger patients.
In our cohort of 1108 patients, there were 23 cases (1.8%) of dura mater tears and CSF leaks after insertion of the dilator instrument in the interspinous space. In 18 cases the CSF fistula occurred at L5-S1 and in 5 cases at the L4-5 level. In all cases the leakage was immediately treated with a muscular graft inserted in the hole and fibrin glue. The dura mater tear occurred especially at the L5-S1 level, where the dural sac is anatomically located more posteriorly, probably secondary to a low insertion of the dilator instrument. To avoid this complication, a more superficial position of the device, in the midportion of the interspinous ligament of L5-S1, should be achieved. Infection risk using an IPD is reduced, although on postoperative MRI we observed a fluid serous collection around the silicone implant (DIAM) in a series of our patients. This was not specifically associated with other clinical conditions, such as fever and infection, and we suggest that it could be related to a temporary host-foreign material reaction.
Our study has several limitations. It is a retrospective study with a follow-up that is not the same among the patients. Moreover, patient age and treated pathology differ from one implant to another. The radiological follow-up is another limitation. Although CT scanning is a more accurate method of detecting fractures of the spinal process, in our study the majority of patients underwent spinal radiography. Another weakness was the absence of a costeffectiveness comparison between IPDs and other surgical approaches for the treatment of lumbar spinal diseases, although that was not the purpose of our study. Such a comparison would have required a different study protocol, one reflecting a variety of complex financial and international issues such as cost reimbursement in the different participating countries.
The perceived advantages of IPD implantation are that it is less invasive than laminectomy, it does not involve destabilizing removal of posterior vertebral elements, and it is reversible. Evidence-based spine trials for IPD are not enough. Indeed, better scientific grounding is needed among spine surgeons when using these devices. We still do not know in which cases the use of an IPD would be considered the gold standard. These devices have numerous indications, including lumbar canal stenosis, degenerative spondylolisthesis (Grade I), discogenic low-back pain, facet syndrome, and lumbar disc herniation, and appropriate application is required for devices with such widespread utility. In our opinion, IPD should be considered a surgical option for patients with comorbidities and a high risk for postoperative complications. Younger patients who can tolerate a more invasive procedure can undergo laminectomy and posterior fixation. 
